They revealed that knockdown of ANGPTL4, NOX 4, and other parameters dramatically inhibited circulating tumor cell extravasation and metastatic seeding of tumor cells in the lungs, indicating that the ANGPTL4/NOX 4 axis is critical for dyslipidemia-associated tumor metastasis. This evidence concerns the gene ANGPTL4 and metabolic syndrome.